These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26892600)

  • 1. DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.
    He TY; Wu DW; Lin PL; Wang L; Huang CC; Chou MC; Lee H
    Sci Rep; 2016 Feb; 6():21483. PubMed ID: 26892600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.
    Wu DW; Lin PL; Cheng YW; Huang CC; Wang L; Lee H
    Oncotarget; 2016 Apr; 7(16):22687-99. PubMed ID: 27007150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway.
    Shen L; Zhang J; Xu M; Zheng Y; Wang M; Yang S; Qin B; Li S; Dong L; Dai F
    Int J Biol Sci; 2022; 18(10):3918-3933. PubMed ID: 35844798
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.
    Heerma van Voss MR; Vesuna F; Trumpi K; Brilliant J; Berlinicke C; de Leng W; Kranenburg O; Offerhaus GJ; Bürger H; van der Wall E; van Diest PJ; Raman V
    Oncotarget; 2015 Sep; 6(29):28312-26. PubMed ID: 26311743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
    Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
    Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFA.
    Lin H; Fang Z; Su Y; Li P; Wang J; Liao H; Hu Q; Ye C; Fang Y; Luo Q; Lin Z; Pan C; Wang F; Zhang ZY
    EBioMedicine; 2017 Apr; 18():62-72. PubMed ID: 28330603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling.
    Zhu C; Luo X; Wu J; Liu Y; Liu L; Ma S; Xie R; Wang S; Ji W
    J Cell Mol Med; 2021 Mar; 25(5):2356-2364. PubMed ID: 31876386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yang F; Fang E; Mei H; Chen Y; Li H; Li D; Song H; Wang J; Hong M; Xiao W; Wang X; Huang K; Zheng L; Tong Q
    Cancer Res; 2019 Feb; 79(3):557-571. PubMed ID: 30563889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling.
    Cruciat CM; Dolde C; de Groot RE; Ohkawara B; Reinhard C; Korswagen HC; Niehrs C
    Science; 2013 Mar; 339(6126):1436-41. PubMed ID: 23413191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
    Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity.
    Zhong J; Zhao M; Ma Y; Luo Q; Liu J; Wang J; Yuan X; Sang J; Huang C
    Int J Mol Med; 2012 Aug; 30(2):430-6. PubMed ID: 22641175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway.
    Chen HH; Yu HI; Cho WC; Tarn WY
    Oncogene; 2015 May; 34(21):2790-800. PubMed ID: 25043297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Vignjevic D; Schoumacher M; Gavert N; Janssen KP; Jih G; Laé M; Louvard D; Ben-Ze'ev A; Robine S
    Cancer Res; 2007 Jul; 67(14):6844-53. PubMed ID: 17638895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KNOCKDOWN OF CASEIN KINASE 1e INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/β-CATENIN SIGNALING.
    Ye LC; Jiang C; Bai J; Jiang J; Hong HF; Qiu LS
    J Biol Regul Homeost Agents; 2015; 29(2):307-15. PubMed ID: 26122218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Wnt signaling by the nuclear pore complex.
    Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.